Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) plus platinum‐etoposide versus platinum‐etoposide alone for first‐line treatment of extensive small cell lung cancer

Gao, Ya, Shi, Shuzhen, Liu, Ming, Wu, Fanqi, Zhang, Junhua, Song, Fujian and Tian, Jinhui (2021) Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) plus platinum‐etoposide versus platinum‐etoposide alone for first‐line treatment of extensive small cell lung cancer. Cochrane Database of Systematic Reviews, 2021 (10). ISSN 1361-6137

[thumbnail of Published_Version]
Preview
PDF (Published_Version) - Published Version
Download (198kB) | Preview

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the efficacy and safety of immune checkpoint inhibitors (anti PD-1 or anti PD-L1) plus platinum-etoposide compared with platinum-etoposide alone for the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC).

Item Type: Article
Uncontrolled Keywords: pharmacology (medical),sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/2700/2736
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Groups > Epidemiology and Public Health
Faculty of Medicine and Health Sciences > Research Groups > Health Services and Primary Care
Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023)
Faculty of Medicine and Health Sciences > Research Centres > Population Health
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 06 Dec 2021 18:18
Last Modified: 06 Apr 2024 01:10
URI: https://ueaeprints.uea.ac.uk/id/eprint/82572
DOI: 10.1002/14651858.CD014809

Actions (login required)

View Item View Item